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1607-551X/Copyright ª 2015, KaohsiuAbstract Early and accurate risk prediction is an important clinical demand in patients with
infective endocarditis (IE). The platelet-to-lymphocyte ratio (PLR) is an independent predictor
of worse prognosis in various cardiovascular diseases. The aim of this study was to determine
the value of PLR in the prediction of in-hospital mortality among IE patients. We retrospec-
tively analyzed the clinical, laboratory, and echocardiographic data of 59 adult patients with
definite IE and in 40 adult controls. In-hospital mortality occurred in 16 (27%) patients. Vege-
tation size, levels of high-sensitive C-reactive protein and procalcitonin, neutrophil-to-
lymphocyte ratio, and PLR were significantly higher in the in-hospital-mortality-positive group
than in the in-hospital-mortality-negative group (pZ 0.004, pZ 0.009, pZ 0.030, pZ 0.001,
and p Z 0.008, respectively). Lymphocyte count was, however, significantly lower in the in-
hospital-mortality-positive group (p Z 0.004). In the receiver-operating characteristic anal-
ysis, PLRs over 191.01 predicted in-hospital mortality with 56.3% sensitivity and 81.4% speci-
ficity [area under the curve 0.725, 95% confidence interval (CI) 0.594e0.833; p Z 0.0027].
In the multivariate analysis, PLR was found to be an independent predictor of in-hospital mor-
tality in patients with IE (odds ratio 1.022, 95% CI 1.003e1.042; pZ 0.021). In conclusion, high-
er PLR may predict in-hospital mortality in patients with IE.
Copyright ª 2015, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.eclare no conflicts of interest.
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Hematologic parameters and infective endocarditis 633IntroductionInfective endocarditis (IE) is the infection of heart valves,
large intrathoracic vessels, and intracardiac foreign bodies
such as the interventricular septum, chordae tendineae, or
mural endocardium. Despite the improvements in the
diagnosis and treatment of IE, the in-hospital mortality and
morbidity rates of this infection remain high [1e4]. Echo-
cardiographic findings, clinical characteristics, and blood
parameters, such as high-sensitive C-reactive protein
(hsCRP) level and white blood cell (WBC) counts, are well-
established markers for disease monitoring [1,5e7]. In
recent years, with the growing understanding of the role of
various inflammatory markers in IE, studies have focused
on new, widely available, and inexpensive inflammatory
markers. In this regard, recent studies have revealed that
various markers including WBC count, neutrophil-to-
lymphocyte ratio (NLR), and mean platelet volume are
associated with IE and its prognosis [4,8e10].
Platelets are well-established components of the he-
mostatic system. Recently, several additional functions of
platelets have been demonstrated in the pathogenesis of
various diseases in which inflammation is an important
clinical sign. Besides, lymphocyte count is inversely corre-
lated with inflammation, and thus, a lower lymphocyte
count indicates an increased risk of cardiovascular disease
and mortality [11,12]. The platelet-to-lymphocyte ratio
(PLR) is positively correlated with inflammation, and
therefore, can be a useful biomarker to predict inflamma-
tion. The PLR is an easily applicable blood test, and can be
performed using a complete blood count analyzer. More-
over, the test does not require any complex or expensive
technologies [13,14]. Recently, PLR was used as a worse
prognostic marker of various cardiovascular conditions
[15e18]. However, there are no data regarding its predic-
tive role in patients with IE. In this study, we aimed to
assess the relationship between PLR levels obtained on
admission and in-hospital mortality in patients with IE.
Methods
We retrospectively analyzed clinical, laboratory, and
echocardiographic data of 62 consecutive adult patients
with definite IE diagnosis between January 2012 and
February 2015 at Adnan Menderes University School of
Medicine, Aydin, Turkey and Celal Bayar University School
of Medicine, Manisa, Turkey. Both centers were using
standardized protocols, uniform data collection methods,
and identical diagnostic and therapeutic criteria for IE.
The study protocol was approved by the Adnan Menderes
University School of Medicine Ethics Committee and the
Institutional Review Board. All patients met the modified
Duke criteria for the definitive diagnosis of IE [5]. Diag-
nostic categories were defined as follows: direct evidence
of vegetative growth in a histologic or bacteriologic study
of the involved tissue or satisfying two major criteria or
one major and three minor criteria or five minor criteria
for IE. Three patients were excluded from the study
because of missing data, and thus data on 59 patients
were analyzed in this study. The healthy volunteers group
included individuals who were admitted to the cardiologyoutpatient unit for check-up. After these exclusions, the
final study population consisted of 59 patients with IE and
age-, sex-matched 40 healthy volunteers (control group).
All clinically relevant data of the patients were stored in
an electronic database. Data collected included patients’
characteristics; laboratory measurements; echocardio-
graphical, microbiological, and pathological findings; need
for surgical valve replacement of the infected valve; and
clinical course of the disease. Microbial pathogens were
detected according to standard methods and established
microbiological guidelines. All patients were followed up
until their discharge from hospital.
Venous blood samples of all patients were collected at
hospital admission, and at least three separate venipunc-
ture sites were used for collecting blood samples (for
sample culture) with 1-hour intervals. Additional samples
were also drawn to examine various specific antibodies.
The extracted tissues during surgery were sent for culture.
The biochemical analysis including glucose, urea, creati-
nine, total protein, albumin, globulin were measured Ar-
chitect C8000 analyzer (Abbot Park, IL, USA). hsCRP were
also measured in the collected blood samples. Procalcitonin
levels were measured by the chemiluminescent immuno-
assay using an auto-analyzer (Maglumi 600, Shaanxi, China)
and hsCRP levels were analyzed using a Beckman Coulter
AU Analyzer (Beckman Coulter, IMMAGE, Immunochemistry
System, USA) in all blood samples. Complete blood count
(CBC) parameters were measured using a Sysmex K-1000
auto-analyzer (Block Scientific, Bohemia, NY, USA). PLR was
directly calculated from CBC results.
Echocardiography (Vivid S5, GE Vingmed Ultrasound A/S,
Horten, Norway) with a 3.5-MHz transducer was performed
and the following data were recorded: left ventricular
ejection fraction (LVEF), presence and length of vegeta-
tion, and presence and degree of valvular dysfunction. The
presence of a myocardial abscess was considered based on
echocardiographical and surgical findings. LVEF was calcu-
lated according to the Simpson method and patients with
LVEF above 55% were considered to have normal systolic
function.
All statistical analyses were carried out using SPSS
version 15.0 for Windows (SPSS Inc., Chicago, IL, USA).
Continuous variables were tested for normal distribution
by the KolmogoroveSmirnov test. Data on continuous
variables were reported as mean and standard deviation
or median (minemax). Continuous variables were
compared using the Student t test or ManneWhitney U
test between groups. Categorical variables were summa-
rized as percentages and compared with the Chi-square
test. Receiver-operating characteristic (ROC) curve anal-
ysis was used to determine optimal cutoff values of PLR
levels to predict the in-hospital mortality rate in patients
with IE. To determine the independent predictors of in-
hospital death, clinical parameters were evaluated by
stepwise forward logistic regression analysis. Multivariate
logistic regression analysis was used to identify indepen-
dent predictors of in-hospital mortality in patients with IE.
The survival curve of PLR during hospitalization was
analyzed using the KaplaneMeier method, and statistical
assessment was performed using the log-rank test. A two-
tailed p value < 0.05 was considered statistically signifi-
cant for all analyses.
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There were 59 patients (mean age 58.5  14.7 years and 25
men) in the IE group and 40 volunteers (mean age
56.9  10.0 years and 22 men) in the control group. Base-
line characteristics and laboratory parameters are shown in
Table 1. Patients in the IE group had significantly lower
LVEF (52.4  11.1% vs. 63.5  4.6%, p < 0.001) than those in
the control group.
With respect to laboratory analyses, creatinine [1.00 mg/
dL (0.56e8.06 mg/dL) vs. 0.78 mg/dL (0.64e1.17 mg/dL),
pZ 0.001] and urea levels [45.0 mg/dL (13.0e184.0 mg/dL)
vs. 33.0 mg/dL (17.0e79.0 mg/dL), pZ 0.001] were signifi-
cantly higher in the IE group than in the control group,
whereas the albumin (3.19 0.62 g/dL vs. 4.00 0.47 g/dL,
p < 0.001) levels were significantly lower in the IE group.
Erythrocyte sedimentation rate [81 hours (25e121 hours) vs.
22 hours (7e38 hours), p < 0.001], hsCRP [118.0 mg/L
(18.8e280.0 mg/L) vs. 1.9 mg/L (0.3e7.8 mg/L), p< 0.001],
and procalcitonin [1.96 ng/mL (0.08e100.00 ng/mL) vs.
0.12 ng/mL (0.01e0.41 ng/mL), p < 0.001] levels were also
significantly higher in the IE group than in the control group.
The CBC test results are as follows: neutrophil count
(11.8 5.9 103 mL vs. 4.6 1.4 103 mL, p< 0.001) and PLR
[133.6 (27.2e677.8) vs. 109.9 (50.6e225.4), p Z 0.026]
levels were significantly higher in the IE group. However,
lymphocyte count (1.7  0.7  103 mL vs. 2.4  0.7 103 mL,
p < 0.001) was significantly lower in the IE group. PlateletTable 1 Baseline characteristics.
Variables Infective endocardi
Age (y) 58.5  14.7
Sex (female/male) 34/25
Diabetes mellitus 18 (31)
Hypertension 19 (32)
Smoker 13 (22)
Laboratory results
Glucose (mg/dL) 130.3  64.9
Urea (mg/dL) 45.0 (13.0e18
Creatinine (mg/dL) 1.00 (0.56e8.
Total protein (g/dL) 6.58  0.84
Albumin (g/dL) 3.19  0.62
Globulin (g/dL) 3.36  0.73
Erythrocyte sedimentation rate (h) 81 (25e121)
hsCRP (mg/L) 118.0 (18.8e2
Procalcitonin (ng/mL) 1.96 (0.08e10
Hemogram
Hemoglobin (g/dL) 10.3  1.7
Platelet (103 mL) 220.6  99.2
White blood cell (103 mL) 14.5  6.3
Neutrophil (103 mL) 11.8  5.9
Lymphocyte (103 mL) 1.7  0.7
Neutrophil-to-lymphocyte ratio 7.1 (1.2e38.9
Platelet-to-lymphocyte ratio 133.6 (27.2e6
Echocardiography result
LVEF (%) 52.4  11.1
Data are presented as n (%), mean  standard deviation, or median (
hsCRP Z high-sensitive C-reactive protein; LVEF Z left ventricular ecount (220.6  99.2  103 mL vs. 252.7  53.0  103 mL,
pZ 0.064) was similar between the two groups. The NLRwas
significantly higher in the IE group than in the control group
[7.1 (1.2e38.9) vs. 2.1 (0.9e3.4), p < 0.001].
Patients with IE were divided into two groups (mortality-
positive and mortality-negative groups) according to in-
hospital mortality (Table 2). Vegetation size, hsCRP, pro-
calcitonin, NLR, and PLR were significantly higher in the in-
hospital-mortality-positive group than in the mortality-
negative group (p Z 0.004, p Z 0.009, p Z 0.030,
pZ 0.001, and pZ 0.008, respectively). Lymphocyte count
was, however, significantly lower in the in-hospital-
mortality-positive group (pZ 0.004).
The ROC curve of PLR for predicting in-hospital mortality
is shown in Figure 1. A PLR level over 191.01, measured
upon admission, had 56.3% sensitivity and 81.4% specificity
in its association with in-hospital mortality [area under the
curve 0.725, 95% confidence interval (CI) 0.594e0.833;
p Z 0.0027]. Figure 2 presents the KaplaneMeier curve for
in-hospital mortality according to the cutoff value of PLR in
patients with IE (log-rank; p Z 0.019).
Some variables associated with in-hospital mortality in
patients with IE were significantly different between the
mortality-positive and mortality-negative groups. The in-
dependent contributions of age, sex, erythrocyte sedi-
mentation rate, hsCRP, procalcitonin, hemoglobin, WBC,
lymphocyte, PLR, NLR, urea, creatinine, albumin, Staphy-
lococcus aureus, vegetation size, and LVEF were analyzedtis (n Z 59) Healthy controls (n Z 40) p
56.9  10.0 0.552
18/22 0.479
11 (28) 0.464
18 (45) 0.140
10 (25) 0.457
109.7  40.4 0.076
4.0) 33.0 (17.0e79.0) 0.001
06) 0.78 (0.64e1.17) 0.001
6.96  0.54 0.090
4.00  0.47 <0.001
3.10  0.48 0.062
22 (7e38) <0.001
80.0) 1.9 (0.3e7.8) <0.001
0.00) 0.12 (0.01e0.41) <0.001
13.3  1.7 <0.001
252.7  53.0 0.064
7.9  1.9 <0.001
4.6  1.4 <0.001
2.4  0.7 <0.001
) 2.1 (0.9e3.4) <0.001
77.8) 109.9 (50.6e225.4) 0.026
63.5  4.6 <0.001
minemax).
jection fraction.
Table 2 Baseline characteristics between in-hospital-mortality-positive and in-hospital-mortality-negative groups.
Variables In-hospital mortality p
Positive group (n Z 16) Negative group (n Z 43)
Men age (y) 61.2  9.8 57.5  16.2 0.396
Sex (Female/Male) 8/8 26/17 0.333
Diabetes mellitus 3 (18.8) 15 (34.9) 0.192
Chronic renal failure 4 (15) 9 (20.9) 0.495
Hospitalization time (d) 42.6  36.1 47.3  36.1 0.654
Previous infective endocarditis 1 (6.3) 2 (4.7) 0.620
LVEF (%) 47.9  11.4 54.1  10.6 0.056
Vegetation size (mm) 16.1 (11.0e35.2) 10.2 (3.1e37.4) 0.004
Surgical therapy 2 (12.5) 14 (32.55) 0.110
Infective endocarditis localization
Native valve 8 (50) 27 (62.) 0.276
Prosthetic valve 8 (50) 11 (25.6) 0.072
Pacemakers 0 (0) 5 (11.6) 0.192
Staphylococcus aureus 9 (56.3) 14 (32.6) 0.097
Erythrocyte sedimentation rate (h) 68.4  30.9 78.8  25.3 0.203
hsCRP (mg/L) 157.7 (73.9e280.7) 103.0 (18.8e273.4) 0.009
Procalcitonin (ng/mL) 6.29 (0.18e70.27) 1.24 (0.08e100.00) 0.030
Hemoglobin (g/dL) 10.2  1.8 10.3  1.7 0.775
Platelet (103 mL) 224.0  93.5 219.4  102.2 0.874
White blood cell (103 mL) 15.5  7.1 14.1  6.0 0.442
Neutrophil (103 mL) 13.1  6.8 11.4  5.5 0.332
Lymphocyte (103 mL) 1.23  0.51 1.85  0.75 0.004
Neutrophil-to-lymphocyte ratio 11.9  7.6 6.7  3.6 0.001
Platelet-to-lymphocyte ratio 199.0 (81.2e677.8) 123.2 (27.2e364.0) 0.008
Data are presented as n (%), mean  standard deviation, or median (minemax).
hsCRP Z high-sensitive C-reactive protein; LVEF Z left ventricular ejection fraction.
Hematologic parameters and infective endocarditis 635using multivariate logistic regression (Table 3). In the
multivariate model, the PLR [odds ratio (OR) 1.022, 95% CI
1.003e1.042; p Z 0.021], NLR (OR 1.337, 95% CI
1.037e1.724; p Z 0.025), lymphocyte (OR 0.011, 95% CI
0.001e0.377; pZ 0.013), vegetation size (OR 1.169, 95% CI
1.014e1.348; p Z 0.032), and hsCRP (OR 1.029, 95% CI
1.002e1.058; p Z 0.036) remained independent predictors
of in-hospital mortality (Table 3).Figure 1. The receiver-operating characteristic curve of
platelet-to-lymphocyte ratio (PLR) for predicting angiographic
in-hospital mortality in patients with infective endocarditis.
AUC Z area under the curve.Discussion
In this study, we investigated the predictive role of
different variables in in-hospital mortality of patients with
definite IE diagnosis. The main findings of this study were as
follows: the PLR is significantly higher in patients with IE
than in healthy controls and higher PLR level on admission is
an independent predictor of in-hospital mortality in pa-
tients with IE.
IE is a life-threatening heart disease, which involves
complex inflammatory processes. Various factors may
contribute to the pathogenesis of IE such as underlying pre-
disposing heart condition, immune deficiency and related
comorbid conditions, addiction of intravenous drugs, and
somecausativemicroorganisms [1]. The in-hospitalmortality
rates for IE continue to remain high (ranging from 15% to 40%)
despite significant improvements in medical technologies
[6]. Despite developments in the field of medicine, the
management, diagnosis, andprediction of IE are challenging.
Figure 2. KaplaneMeier curve for in-hospital mortality ac-
cording to the cutoff value of platelet-to-lymphocyte ratio in
patients with infective endocarditis (log rank, p Z 0.019).
636 C. Zencir et al.Echocardiographic findings, clinical characteristics, and
blood count parameters arewell-establishedmarkers for the
diagnosis and monitoring of this infection [1,5,6]. Conven-
tional and easily available markers such as the hsCRP level
and total WBC counts have been widely used for assessment
of IE [7]. Accordingly, higher total WBC count on admission
has been shown to be a significant and independent predictor
of mortality in patients with IE [8].
Regardless of the fact that a number of biomarkers have
been found to be related with the prognosis of IE, they are
still not routinely used in clinical practice, except echo-
cardiographic findings (such as vegetation size) and hsCRP.
Thus, it is worthwhile and necessary to investigate new,
widely available, and inexpensive predictors for IE. InTable 3 Effects of multiple variables on the in-hospital mortal
Variables Unadjusted OR
Age 1.006 (0.967e1.047)
Sex 1.231 (0.445e3.406)
Erythrocyte sedimentation rate 0.988 (0.970e1.006)
hsCRP 1.008 (1.000e1.016)
Procalcitonin 1.011 (0.992e1.030)
Hemoglobin 1.035 (0.789e1.358)
White blood cell 1.036 (0.947e1.133)
Lymphocyte 0.205 (0.064e0.659)
Platelet-to-lymphocyte ratio 1.003 (1.000e1.006)
Neutrophil-to-lymphocyte ratio 1.333 (1.073e1.657)
Urea 1.011 (0.999e1.022)
Creatinine 0.975 (0.730e1.303)
Albumin 0.429 (0.164e1.120)
Staphylococcus aureus 1.931 (0.714e5.219)
Vegetation size 1.072 (1.008e1.140)
LVEF % 0.976 (0.938e1.016)
hsCRP Z high-sensitive C-reactive protein; LVEF Z left ventricular e
a Adjusted for hsCRP, white blood cell, lymphocyte, platelet-to-ly
vegetation size.recent years, with the growing understanding of the role of
various inflammatory markers in IE, studies have been
focused on other inflammatory markers. Turak et al. [9]
retrospectively analyzed 121 patients with definite IE and
hypothesized that increased NLR level on admission would
predict unfavorable in-hospital outcomes. They showed
that NLR on admission is an independent predictor of in-
hospital mortality in IE cases [9]. Bozbay et al. [10] also
investigated the role of NLR in IE. They found an indepen-
dent association between NLR and in-hospital mortality in
patients with IE. However, there was not any association
between NLR and long-term outcomes. In our study,
consistent with the literature, hsCRP and NLR were signif-
icantly higher in patients with IE than in healthy controls. In
addition, vegetation size, hsCRP, and NLR were indepen-
dently associated with in-hospital mortality in patients with
IE. However, to the best of our knowledge, there is no
similar study assessing the association of PLR with IE and in-
hospital mortality.
In recent years, an association between PLR and various
cardiovascular disorders has been demonstrated. It has been
clearly demonstrated that higher PLR on admission is inde-
pendently associated with worse clinical outcomes in pa-
tients with coronary artery disease during both in-hospital
stays and long-term follow-up periods [19e21]. CBC is a
widely available and inexpensive test that provides impor-
tant data about the properties of various blood cells such as
platelets and lymphocytes. Platelets are well-established
components of the hemostatic system. Recently, several
additional functions of platelets have been demonstrated,
especially in the process of inflammation. There is growing
data about the critical role of platelets in inflammation.
Platelets release numerous inflammatory mediators. Many
of these mediators modify leukocyte and endothelial re-
sponses via different inflammatory stimuli [22]. Owing to
their interactions with neutrophils, lymphocytes, and the
endothelium, platelets play a pivotal role in inflammationity in univariate and multivariate regression analysis.
p Adjusted ORa p
0.755
0.690
0.201
0.058 1.029 (1.002e1.058) 0.036
0.269
0.804
0.437 1.012 (0.898e1.140) 0.845
0.008 0.011 (0.001e0.377) 0.013
0.030 1.022 (1.003e1.042) 0.021
0.010 1.337 (1.037e1.724) 0.025
0.079 0.988 (0.956e1.021) 0.472
0.866
0.084 0.327 (0.043e2.489) 0.280
0.195
0.028 1.169 (1.014e1.348) 0.032
0.234
jection fraction; OR Z odds ratio.
mphocyte ratio, neutrophil-to-lymphocyte ratio, urea, albumin,
Hematologic parameters and infective endocarditis 637and both innate and adaptive immune responses. Numerous
research groups have shown the important roles of platelets
in the pathogenesis of various inflammatory clinical condi-
tions. In previous epidemiological studies, platelet counts
were found to be elevated in patients with chronic inflam-
matory diseases, malignancies, and myeloproliferative dis-
orders [23,24]. Moreover, epidemiological evidence also
supports the fact that antiplatelet medications may affect
host immunity. Besides, they were also associated with
reduced mortality in patients with sepsis, without causing
excessive bleeding in these patients [25,26].
Lymphocytopenia is a common finding in chronic in-
flammatory conditions because of increased stress and
consequent lymphocyte apoptosis. Mechanisms of lympho-
cytopenia are apoptosis due to proinflammatory cytokines,
increased catecholamine and cortisol levels, and redistri-
bution of lymphocytes to lymphatic organs [27,28]. Previous
studies have demonstrated that lymphocytopenia is inde-
pendently associated with the severity of infectious disease
and bacteremia [29,30].
Because PLR is a ratio, it is relatively more stable than
individual blood parameters, which may be altered by
several variables (e.g., dehydration, overhydration, and
blood specimen handling) [31]. The advantage of PLR
calculation could be that it reflects the condition of both
aggregation and inflammatory pathways and it may be more
valuable than either platelet or lymphocyte count alone in
the prediction of various inflammatory diseases including
cardiovascular diseases [19,32]. In a previous study, Azab
et al. [33] showed that lower lymphocyte and higher
platelet counts were significantly related to worse prog-
nosis in patients with non-ST-elevation myocardial infarc-
tion. They also showed that the effect of PLR on mortality
was independent of platelet or lymphocyte counts alone.
Besides, in another study, Gary et al. [34] reported that PLR
was significantly correlated with inflammatory indicators
such as C-reactive protein and fibrinogen in patients with
limb ischemia. In the light of previous studies on PLR, it can
be rationale to hypothesize that there may be associations
between PLR, IE, and in-hospital mortality.
The limitations of our study were its retrospective
design and the presentation of only two-center experi-
ences. The study has a relatively small sample size, and
these results should be confirmed by further studies. In this
study, we especially focused on the assessment of the
relation between PLR levels on admission and in-hospital
mortality. We designed the study protocol in this direction
and performed our analyses solely based on blood test re-
sults at admission.
Our study is the first clinical study demonstrating that
PLR levels are significantly higher in IE patients and inde-
pendently associated with in-hospital mortality of these
patients. The PLR, which can be easily measured from CBC
data, is a simple, widely available, and inexpensive
parameter. Thus, PLR may be a useful marker for monitoring
IE and predictor of in-hospital mortality in patients with IE.References
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